Corden Pharma Experts taking care. APIs DRUG PRODUCTS FACILITIES PLATFORMS ABOUT US CONTACT US Leadership Home About Us Leadership CordenPharma Leadership Team CordenPharma was created in 2006 as a privately held pharmaceutical brand of International Chemical Investors Group (ICIG). With 8 cGMP facilities across Europe and the US, CordenPharma is headed by a Leadership Team which includes CordenPharma International (CPI) Leadership, CPI Platform Directors, and CordenPharma Facility Managing Directors. CordenPharma International (CPI) Leadership Ernesto Petroselli President, CordenPharma International (CPI) Mr. Ernesto Petroselli joined CordenPharma in 2012 as Managing Director of CordenPharma Latina (IT). In 2013 he assumed the role of President, CordenPharma International, while continuing to serve as Interim Managing Director of CordenPharma Latina. Prior to joining CordenPharma, Ernesto gained extensive operations and management experience over 30 years of progressive responsibility working in various positions at Johnson & Johnson Pharma from Operations Manager and VP of Operations in Europe and Asia, to VP, Global Pharmaceutical Network and VP, Global OTC Supply Chain. Other work experience includes Dow-Lepetit Garessio, Dow Chemical-Livorno, and Coca Cola Export Corporation in the Balkan States and North Africa. Ernesto holds a degree in Mechanical Engineering. Dr. Christian Ewers Vice President, CordenPharma International (CPI) Interim Managing Director, CordenPharma Plankstadt Dr. Christian Ewers joined CordenPharma in 2012 as the Managing Director of CordenPharma Switzerland. In June of 2013 he became Chief Operating Officer of CordenPharma International API business with oversight of CordenPharma Colorado, CordenPharma Switzerland, Farchemia and CordenPharma France. In 2014 his role slightly changed to become Vice President, CordenPharma International, with oversight over all CordenPharma facilities dealing with Peptides, Carbohydrates, Lipids and Injectables. Dr. Ewers also currently serves as the Interim Managing Director, CordenPharma Plankstadt (DE). Dr. Michael Quirmbach Vice President, Global Sales & Marketing, CordenPharma International (CPI) Dr. Michael Quirmbach joined CordenPharma in October 2014 as the Vice President, Global Sales & Marketing, CordenPharma International. Prior to joining CordenPharma Michael held positions with increasing responsibility at Siegfried AG, Dr. Reddy's, Solvias AG, Speedel, and Albany Molecular Research (AMRI), where he garnered extensive experience in business development, marketing, and sales in the CDMO arena. Michael studied chemistry at the Technical University of Clausthal (DE) and the University of Salford (UK) before completing his PhD at the the Max Planck Research Group “Asymmetric Catalysis” at the Institute for Organic Catalysis Research in Rostock (DE). Following a postdoctoral fellowship at both the University of Colorado, Boulder (USA) and the University of Pennsylvania (USA), Michael completed his MBA from La Salle University in Philadelphia (USA) in 2005. Dr. Siegmund Kunz Director, Compliance, CordenPharma International Dr. Siegmund Kunz assumed the role of Director, Compliance, CordenPharma International in 2014, after joining CordenPharma Plankstadt as Head of Quality & Compliance in 2008. With over 20 years of experience in the field of Solid Dosage Formulation, he began his career in 1993 with ZENECA as Production Support Manager. Following this he served as Supply Chain Manager, NPI Manager and Production Manager for ZENECA. From 2002 – 2007 he was Head of Quality & Compliance for AstraZeneca Germany. Siegmund Kunz is a Pharmacist by education and holds a PhD in Pharmaceutical Biology from the Universität des Saarlandes / Germany. CPI Technology Platform Directors Dr. Mimoun Ayoub Director, Global Peptides / Lipids / Carbohydrates & Injectables Platforms, CordenPharma International (CPI) Dr. Mimoun Ayoub joined CordenPharma in November 2013 following the acquisition of Peptisyntha by ICIG as Director, Global Peptides / Lipids / Carbohydrates & Injectables Platform, CordenPharma International. With over 20 years of experience in the pharmaceutical industry, Mimoun served as Vice President, Global Business & Strategy of Peptisyntha, as well as a member of the Peptisyntha Executive Team and Solvay Life Sciences Leadership Team prior to joining CordenPharma. He also held various senior and executive positions within global pharmaceutical manufacturing companies including Chief Executive Officer, Senn Chemicals, Head of Manufacturing Operations, Senn Chemicals, and Head of Manufacturing and Chemistry at Genzyme Pharmaceuticals. Mimoun holds a Ph.D. in Organic Chemistry from the French University Pierre & Marie-Curie and is still very well connected to the field of academic research. Dr. Roberto Margarita Director, Global Antibiotics & Oncology Platforms, CordenPharma International (CPI) Dr. Roberto Margarita joined CordenPharma in 2010 with current responsibility both as Director, Global Antibiotics & Oncology Platform, CordenPharma International, and New Product Introduction activities for CordenPharma Latina Operations. Prior to joining CordenPharma, Roberto managed business development and strategic planning for Bristol Myers Squibb, where he also developed an extensive and diverse background in manufacturing as Active Pharmaceutical Ingredient (API) Business Unit Director. Roberto’s various leadership positions in the pharmaceutical development areas of Chemistry, Manufacturing Control, and CMC lead to multiple NDAs. In addition Roberto brings expertise in customer relationship management, strategic operation planning in FDA approved sites, P&L, outsourcing and divestiture. He holds a Ph.D. in Chemical Sciences from the University of Rome “la Sapienza”, with Post-Doctoral experience at the Université de Montreal, Canada and a Diploma in General Management from the Henley Management College (UK). Luca Porcu Director, Global Highly Potent & Small Molecules Platforms, CordenPharma International (CPI) Luca Porcu joined CordenPharma in 2012 as Sales Manager and in 2013 was appointed Director, Global Highly Potent & Small Molecules Platform, CordenPharma International. With over 15 years of experience in the global pharmaceutical industry, Luca held various sales and production positions such as Sales Manager, Business Manager, Production Manager, Finished Product Manager and Generic Pharmaceutical Dossier Manager for Patheon, Zambon Chemical, Cell Therapeutics and ZaCh System. Luca holds a degree in Pharmaceutical Chemistry from the University of Study Ferrara (IT) and served as a Researcher and Professor for several years after earning his degree. CordenPharma Facility Managing Directors Angelo Colombo Managing Director, CordenPharma Caponago Angelo Colombo joined CordenPharma is July 2011 as Managing Director, CordenPharma Caponago (IT). Angelo started his career at Farmitalia Carlo Erba and then went on work in several roles of increasing responsibility at Pharmacia / Pfizer, followed by Pierrel and Shering Plough. With over 20 years of experience working in various facilities with the highest quality and safety standards, Angelo has gained extensive expertise in injectable manufacturing in different pharmaceutical forms. He graduated with a degree in Chemical and Pharmaceutical Technologies at the University Statale of Milan. Yves Michon Managing Director, CordenPharma Chenôve Yves Michon joined CordenPharma in January 2011 as Managing Director, CordenPharma Chenôve (FR). Yves brings 30 years of experience in the manufacturing and business of Fine Chemicals and APIs with expertise in Production, Continuous Improvement, Project Management and General Management of CMOs. He holds a Master of Science Degree in Process Control & Engineering from ECAM Graduate School of Engineering in Lyon, France. Brian McCudden Managing Director, President & CEO, CordenPharma Colorado Brian McCudden joined CordenPharma as Managing Director, CordenPharma Colorado (Boulder, CO, USA) in June 2014. Brian is an API executive with extensive experience developing and implementing strategy and building high performing teams. He has broad experience at establishing and improving operations in development, manufacturing, supply chain, sourcing and procurement in API and finished Drug Product. Brian graduated from the University of Delaware with a degree in Chemical Engineering and has an MBA in Finance from Loyola College. Prior to accepting his current position with CordenPharma Colorado, he served as the Vice President, API Strategy at Hospira. Brian also worked for Roche Colorado Corporation as Director of Manufacturing from 1991 - 2002. Laura Coppi Managing Dirctor, Farchemia Laura Coppi joined CordenPharma in October 2013 as Managing Director, Farchemia (IT) after more than 20 years of experience in various management positions in the pharmaceutical chemical industry. Laura began her career in Process R&D at Zambon Group in 1988. In 1992 her professional pathway shifted toward business and management as Technical Marketing Manager, EAME Generic Sales Manager and Worldwide Contract Manufacturing Manager at Zambon. In 1998 Laura came to the USA to work for Davos Chemical Corporation as Technical Marketing and Key Account Manager. In 1998, Laura went back to Europe and worked for 9 years at the Spanish private group Esteve as R&D and IP Director (Esteve Quimica) and General Manager (Pensa Pharma in Milan). In 2007, Laura joined Wyeth Pharmaceuticals’ New Product and Process Development division as Sr. Director of API Technical Operations, followed by positions as Managing Director of Archimica Srl and Marketing and Sales Director of F.I.S. As an Organic Chemist of the University of Florence, Specialist in Synthetic Organic Chemistry of the University of Milan and author of several publications and patents, Laura complemented her scientific education with a diploma in Marketing from Bocconi University in Milan and a PDG from Iese in Barcelona. Emilio Frongia Managing Director, CordenPharma Latina Emilio Frongia serves as the Managing Director, CordenPharma Latina (IT), after joining CordenPharma in 2010 as Director of Finance & Logistics. Emilio began his career in the consumer electronics business before moving to the pharmaceutical industry to join Alfa Wassermann in 1996 as Financial Controller and Bristol-Myers Squibb in 2006 as Finance Director. Emilio holds a degree in Economics and a CA certification from the University of Rome. Piet Serrure Managing Director, Peptisyntha Piet Serrure joined CordenPharma in 2014 as Managing Director, Peptisyntha (BE). With more than 25 years of practitioner’s experience in the Private Equity Industry focusing on direct investments, Piet started his career in 1976 at Arthur Andersen, held sales and marketing functions at Du Pont de Nemours from 1980 – 1986 and began his private equity career at Benevent in 1985. Piet founded the Belgian branch of Parnib (NIB Capital) in 1992, where he was Director and C.E.O. In 2001 he then founded Origo Management, a specialised consultant firm to the private equity industry, followed by Becap, an investor in secondaries, in 2006. Piet Serrure was one of the early investors in the European biotech industry and was a member of the Board of Directors of several public and private biotech companies. He continues to be a board member at Hybrigenics (Paris) and Bio.be (Brussels). Piet Serrure holds a master degree in Economic Sciences from the University of Antwerp (BE). Dr. Jürg Burger Managing Director, CordenPharma Switzerland Dr. Jürg Burger joined CordenPharma in 2013 as the Managing Director, CordenPharma Switzerland (CH), with oversight of facilities in both Liestal, CH and Woburn, MA, USA. Prior to joining CordenPharma, Dr. Burger garnered extensive operations management experience over 27 years in various roles at Lonza AG (CH and Hopkinton, US) including Head of Manufacturing Business Sector Exclusive Synthesis, Head of Manufacturing Operations for Pharmaceuticals (small molecules) and later Microbial Fermentations, and most recently Head Business Unit of Global Microbial Operations, VP of Supply Chain and VP of Head Site Services. Jürg earned a PhD and Master Degree in Chemical Engineering from the Swiss Federal Institute of Technology in Zurich (CH). Contact our team of experts to place an inquiry. CONTACT US About Us Leadership Our History Compliance News and Press Events ICIG Careers Browse brochures & presentations to learn more about CordenPharma. RESOURCE CENTER Corden Pharma ©2012 CordenPharma International Media Contact Impressum Terms and Conditions Privacy Policy Website by Boston Interactive Facebook LinkedIn Corden Pharma International GmbH, Otto-Hahn-Strasse, 68723 Plankstadt, Germany. APIs API Development API Contract Manufacturing Generic API Manufacturing Highly Potent APIs Sterile APIs Peptides Building Blocks Conjugate Products Carbohydrates Derivatized Phospholipids Support Services Drug Products Drug Product Development Drug Product Contract Manufacturing Generic Drug Manufacturing Sterile Formulation Highly Potent Formulation Oncology Cephalosporin Manufacturing Penicillin Manufacturing Parenterals Large Pre-Filled Syringes Sterile Oncology Oral Oncology Two-layer tablets Clinical Supply Services Packaging Pharma-Logistics Support Services Facilities Bergamo, IT Brussels, BE Caponago, IT Chenôve, FR Colorado, US Latina, IT Plankstadt, DE Liestal, CH Platforms Antibiotics Oncology Highly Potent Small Molecules Peptides / Lipids / Carbohydrates Injectables About Us Leadership Our History Compliance News and Press Events ICIG Careers Contact Us Find Your Expert Schedule an Appt